Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Lang

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 1, 2026
Prophylactic sequential drug administration potentiates cancer radiotherapy by inhibiting cholesterol deposition and cellular senescenceShanshan Lang, Xulu Yang, Xin Zhao, et al.
Cell Reports|September 21, 2017
Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V<sub>H</sub>1-69 Antibody Orientation on the HA StemShanshan Lang, Jia Xie, Xueyong Zhu, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 2, 2026
Emerging Biomaterials Blocking PD-1/PD-L1 Pathway for Cancer TherapyYi Zhu, Jiawei Song, Yansheng Zhu, et al.
Plant, Cell & Environment|October 8, 2022
The active Fe chelator proline-2'-deoxymugineic acid enhances peanut yield by improving soil Fe availability and plant Fe statusTianqi Wang, Nanqi Wang, Qiaofang Lu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 10, 2026
Reprogramming Tumor-Associated Neutrophils to Enhance Radio-ImmunotherapyXulu Yang, Shanshan Lang, Tongtong Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 3, 2024
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapyYanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2025
Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapyYue Liu, Yanxiang Zhang, Xulu Yang, et al.
Cell Host & Microbe|November 24, 2019
Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase AntibodiesXueyong Zhu, Hannah L Turner, Shanshan Lang, et al.
Plos Biology|February 5, 2019
Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domainsHannah L Turner, Jesper Pallesen, Shanshan Lang, et al.
Blood|June 11, 2014
Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cellsCathy X Wang, Blythe D Sather, Xuefeng Wang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 1, 2026
Prophylactic sequential drug administration potentiates cancer radiotherapy by inhibiting cholesterol deposition and cellular senescenceShanshan Lang, Xulu Yang, Xin Zhao, et al.
Cell Reports|September 21, 2017
Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V<sub>H</sub>1-69 Antibody Orientation on the HA StemShanshan Lang, Jia Xie, Xueyong Zhu, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 2, 2026
Emerging Biomaterials Blocking PD-1/PD-L1 Pathway for Cancer TherapyYi Zhu, Jiawei Song, Yansheng Zhu, et al.
Plant, Cell & Environment|October 8, 2022
The active Fe chelator proline-2'-deoxymugineic acid enhances peanut yield by improving soil Fe availability and plant Fe statusTianqi Wang, Nanqi Wang, Qiaofang Lu, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 10, 2026
Reprogramming Tumor-Associated Neutrophils to Enhance Radio-ImmunotherapyXulu Yang, Shanshan Lang, Tongtong Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 3, 2024
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapyYanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2025
Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapyYue Liu, Yanxiang Zhang, Xulu Yang, et al.
Cell Host & Microbe|November 24, 2019
Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase AntibodiesXueyong Zhu, Hannah L Turner, Shanshan Lang, et al.
Plos Biology|February 5, 2019
Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domainsHannah L Turner, Jesper Pallesen, Shanshan Lang, et al.
Blood|June 11, 2014
Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cellsCathy X Wang, Blythe D Sather, Xuefeng Wang, et al.
Pageof 2